🚨 #ClinicalTrials Plenary at #AACR25@DrUppaluri presents KEYNOTE-689 perioperative pembrolizumab + SOC improves EFS in locally advanced resectable HNSCC
🔹Subgroup analysis: no EFS benefit in stage IVA
🔹mPR 13.7% in CPS >=10
🔹Lower rates of path high-risk features postoperatively in pembro arm
🔹Trend towards improved OS, but did not meet statistical significance at 1st interim analysis
#HNCSM
🚨 Come & join @royalmarsdenNHS for a 2-year fellowship to conduct clinical research in cancer in older adults in a very supportive team with the opportunity to register for a research degree at @ICR_London
Info available here: https://t.co/88WcEFtC4U
Closing date: 22/11/2024
#gerionc #bcsm
🚀 Already looking forward to the results of the IMPORTANT-trial, investigating lower starting doses of #CDK4/6 inhibitors and the role of the #geriatric assessment in older adults with mBC
Congratulations to the authors for enrolling this study!
https://t.co/BvFjzW5qHd
Our Fundamentals in Oncology Education Course 2024 has just launched! @stjamesdublin@CancerInstIRE
Register for a ticket 🎟 on Eventbrite https://t.co/HSK5WIdZAQ
Dr Goggin and her co-investigators present a study revealing 57% cancer survivors have ⬇️ social networks. Only 37% of older patients had access to computer/internet 🖥️. ⬆️social isolation than general population. @GogginCaitriona#survonc#supponc
https://t.co/fwGT6sBR3i
New #JITC review: Inclusion, characteristics, and reporting of older adults in FDA registration studies of immunotherapy, 2018–2022 https://t.co/mlgRjNZWna @CEochagain@CancerhealingDr@nicolobattisti
We were delighted to be in @stjamesdublin today for this fantastic meeting with #TSJCI . @RoseAnnekenny1 in full flight presenting an overview of TILDA:
"The number of people with functional limitations will increase 5 fold by 2040"
Looking forward to further collaboration with colleagues in cancer to grow opportunities for longitudinal data collection in #cancer survivors in collaboration with @tilda_tcd
🇪🇺🗣️If you’re a Healthcare Professional with experience in cancer service provision for patients with a physical or intellectual disability over 65 years-old - consider participating in this @IrishCancerSoc funded EuCan Study. 💙
Contact: Shauna Walsh: [email protected]
Cardiovasular disorders - associated with cancer - different risk factors in cancer and highest in haematological cancers and lung. @AoPgbi@stjamesdublin@TrinityMed1
Hot off the press the new @ASCO@myESMO global curriculum recommendations for Cancer Care in Older Adults #gerionc
Every oncologist should have key competencies in geriatric care! We hope this gets integrated in programs globally @HansWildiers @SIOGorg
https://t.co/zMPr2Ql4iL
Do we have the right priorities in oncology #ESMO2023#ESMO23 - pictures taken a few minutes apart. Supportive care and Investigational therapy poster areas. Clinically these two are intertwined.
🎙️The next YSIOG forum will be held next week!🎙️
Date: Thursday November 2, 07:00 PM - 08:00 PM CET time
Location: Zoom
The Zoom link has been emailed to all YSIOG members. Looking forward to seeing you all next Thursday!